Health Status of Patients After Surgically Implanted Biological and TAVI: a Population-based Retrospective Analysis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05912660

Enrollment

18882

Registered

2023-06-22

Start date

2010-01-01

Completion date

2020-12-31

Last updated

2023-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Disease

Brief summary

The overall project aim is to study outcomes following aortic valve replacement with surgically implanted bioprostheses or TAVI by retrieving data from the main social security carriers in Austria for the years 2010-2020.

Interventions

DEVICEAortic Valve Replacement

Aortic Valve Replacement (surgically or TAVI)

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

65 Years to 99 Years

Healthy volunteers

Inclusion criteria

* isolated aortic valve replacement in Austria (surgically implanted bioprostheses or TAVI)

Exclusion criteria

* below 65 years of age * coronary revascularization within 4 months before the index procedure * concomitant heart surgery

Design outcomes

Primary

Measure	Time frame	Description
all-cause mortality	10 years	all cause mortality after aortic valve replacement

Secondary

Measure	Time frame	Description
reoperation	10 years	incidence of reoperation after aortic valve replacement
myocardial infaction	10 years	incidence of myocardial infaction after aortic valve replacement
heart failure	10 years	incidence of heart failure after aortic valve replacement
stroke	10 years	incidence of stroke after aortic valve replacement

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026